Hospital
Evergreen Medical Center LLC
Evergreen Medical Center LLC was paid $934K by Medicaid between Jan 2018 and Nov 2024, across 37 billing codes. Its largest line is 99284, emergency room visit (serious) — 63% of everything it billed.
33Billing provider infoEVERGREEN MEDICAL CENTER LLC
EVERGREEN, AL 36401
EVERGREEN, AL 36401
33aNPI1891770368assigned 12/07/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$934K
24GClaims28,930
24DCodes billed37
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Alabama
Rank by total paid#45 of 77
Median peer was paid$1.13M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,692 | $117K | |
| 2019 | 5,115 | $146K | |
| 2020 | 2,296 | $95K | |
| 2021 | 2,674 | $112K | |
| 2022 | 3,664 | $146K | |
| 2023 | 5,060 | $191K | |
| 2024incomplete | 4,429 | $127K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 63% | 11,450 | 7,447 | $592K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 3,801 | 2,305 | $120K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 1,258 | 880 | $119K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.6% | 1,988 | 936 | $24K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.0% | 627 | 579 | $18K |
| 80053 | Comprehensive metabolic panel | 1.9% | 1,979 | 1,717 | $17K |
| 85027 | <1% | 2,518 | 2,139 | $9K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 255 | 139 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 399 | 369 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 114 | 110 | $5K |
| 83735 | <1% | 648 | 557 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 186 | 168 | $2K |
25 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 54 | $1K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 17 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 717 | $756.26 |
| 81003 | <1% | 355 | $700.21 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 34 | $646.07 |
| 82553 | <1% | 54 | $583.70 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 87 | $573.50 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 60 | $516.20 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 75 | $476.97 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 16 | $422.46 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 326 | $415.85 |
| 84484 | <1% | 68 | $414.96 | |
| 81025 | <1% | 101 | $384.73 | |
| 80306 | <1% | 29 | $370.48 | |
| 81001 | <1% | 84 | $360.96 | |
| 86328 | <1% | 12 | $348.26 | |
| 87186 | <1% | 25 | $200.25 | |
| 83880 | <1% | 14 | $195.72 | |
| 87077 | <1% | 25 | $187.04 | |
| 71045 | Radiologic examination, chest; single view | <1% | 50 | $174.80 |
| 87807 | <1% | 13 | $163.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 376 | $159.60 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 22 | $96.00 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,004 | $2.24 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 89 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJONES, SHARON (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Evergreen Medical Center LLC | Evergreen, AL | $238K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.